Thank you for sharing!

Your article was successfully shared with the contacts you provided.
a package of the drug Vytorin. A package of the drug Vytorin

Federal securities law does not preclude Merck and Schering-Plough investors from bringing individual suits against the drugmakers under state law after opting out of a securities class action settlement, the U.S. Court of Appeals for the Third Circuit ruled Friday.

Charles Toutant

Charles Toutant is a litigation writer for the New Jersey Law Journal.

More from this author


Wage Hour Collective and Class LitigationBook

Given the recent explosion of wage and hour litigation, both management- and plaintiff-side attorneys will find this publication to be an invaluable reference. With ...
Get More Information


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.